Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
13(12):2055-8
Formula: C27H21N3O5
CHR-6494 shows antitumor potential in xenografted nude mice without any observed toxicity
InChi: InChI=1S/C2H7NS/c3-1-2-4/h4H
Epub 2011 Aug 30
NS-304 Size:Solid 2 mg 13(12):2055-8Selexipag, also known as ACT 293987 and NS 304, is a a first in class orally available selective non prostanoid IP receptor agonist, which is currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT 333679, are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. Product information CAS Number: 475086 01 2 Molecular Weight: 496. 62